BRITTANY BELER: Open Payments
NPI 1134902968 · RIVERTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 56 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $208 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 39 | $334 |
| Novo Nordisk Inc | 5 | $104 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| Abbott Laboratories | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Recor Medical Inc | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: LEQVIO, Wegovy, AMVUTTRA, JOT DX, CAMZYOS, EVKEEZA, Paradise Ultrasound Renal Denervation System, VERQUVO.
Industry payments across IL — which companies pay providers there.
